Issue link: https://www.e-digitaleditions.com/i/1208415
Inhalation February 2020 27 Validated IVIVC systems De-risking the development of generic inhaled drug products is a key objective of the industry. Copley Sci- entific's range of validated IVIVC systems allow users to compare test and reference products under a range of more clinically relevant test conditions, thereby boost- ing the likelihood of clinical success and potentially avoiding in vivo testing altogether. Our range of in vitro testing solutions help target key critical quality attri- butes of inhaled drug products, allowing users to better understand and characterize their products on the road to demonstrating bioequivalence. Copley Scientific UK: +44 1159 616229 www.copleyscientific.com A generic device for fluticasone, umeclidinium and vilanterol Merxin brings you a dual cavity device for triple ther- apy, based on the open-inhale-close principle. The latest AB-rated device from the team at Merxin is the MRX006. Designed for drugs that just don't like each other, the MR X006 accommodates a combi- nation formulation of two or more APIs; providing unequalled technology tailored to current regula- tions and high-performance expectations. Merxin is a designer and supplier of inhalers that treat lung diseases, reduce vaping risks and make cannabis therapies reli- able. We make the world healthier, one breath at a time. Our DNA is in the pharma industry; we deliver quality, reliability and efficacy. Merxin UK: +44 1553 403070 www.merxin.com Inhalation aerosol generator Minimize error, reduce risk and accelerate your inhaled drug development. PreciseInhale ® puts you in control of your aerosol—and your outcomes—with data so pre- cise your research will be leading. Its "precision dosing" technique generates repeatable, predictive PK data with typical standard deviation of < 10%, using one animal at a time or the advanced in vitro dissolution module DissolvIt. For IVIVC findings of unparalleled precision and full 3R compliance, get the power of preclinical precision with the PreciseInhale aerosol generator. Inhalation Sciences Sweden: +46 736 289 153 www.preciseinhale.com Reducing OINPD testing variability Removing repetitive tasks usually performed by ana- lysts is critical to improving test reliability and integrity. Basic automation improves throughput and promotes efficient labor utilization to ensure analysts are working on meaningful and value-added activities. MSP, a divi- sion of TSI, carries a wide range of automated solutions, performing basic functions to more fully automated operations. State-of-the-art automation reduces errors and variation, resulting in more reliable, consistent, dependable data and a streamlined method transfer. MSP, a division of TSI US: +1 651 287-8100 www.tsi.com